These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30710592)

  • 1. In silico identification and wet lab validation of novel cryptic B cell epitopes in ZnT8 zinc transporter autoantigen.
    Shruthi S; Mohan V; Maradana MR; Aravindhan V
    Int J Biol Macromol; 2019 Apr; 127():657-664. PubMed ID: 30710592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes.
    Skärstrand H; Lernmark A; Vaziri-Sani F
    Scand J Immunol; 2013 Jan; 77(1):21-9. PubMed ID: 23126564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel autoantibodies to the β-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes.
    Gu Y; Merriman C; Guo Z; Jia X; Wenzlau J; Li H; Li H; Rewers M; Yu L; Fu D
    J Autoimmun; 2021 Aug; 122():102677. PubMed ID: 34130115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants.
    Faccinetti NI; Guerra LL; Penas Steinhardt A; Iacono RF; Frechtel GD; Trifone L; Poskus E; Trabucchi A; Valdez SN
    Eur J Endocrinol; 2016 Feb; 174(2):157-65. PubMed ID: 26567119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc transporter 8 autoantibodies (ZnT8-ab) are associated with higher prevalence of multiple diabetes-related autoantibodies in adults with type 1 diabetes.
    Rogowicz-Frontczak A; Pilacinski S; Wyka K; Wierusz-Wysocka B; Zozulinska-Ziolkiewicz D
    Diabetes Res Clin Pract; 2018 Dec; 146():313-320. PubMed ID: 30465779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.
    Vaziri-Sani F; Delli AJ; Elding-Larsson H; Lindblad B; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Marcus C; Lernmark Å
    J Immunol Methods; 2011 Aug; 371(1-2):25-37. PubMed ID: 21708156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients.
    Skärstrand H; Krupinska E; Haataja TJ; Vaziri-Sani F; Lagerstedt JO; Lernmark Å
    Clin Exp Immunol; 2015 Feb; 179(2):220-9. PubMed ID: 25178386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes Mellitus.
    Yi B; Huang G; Zhou ZG
    Chin Med J (Engl); 2015 Sep; 128(17):2387-94. PubMed ID: 26315089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc transporter 8 (ZnT8) autoantibody prevalence in black South African participants with type 1 diabetes.
    Bhola S; Cave EM; Bhana S; Crowther NJ; Padoa CJ
    BMC Endocr Disord; 2021 Jul; 21(1):151. PubMed ID: 34271898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes.
    Niechciał E; Rogowicz-Frontczak A; Piłaciński S; Fichna M; Skowrońska B; Fichna P; Zozulińska-Ziółkiewicz D
    Acta Diabetol; 2018 Mar; 55(3):287-294. PubMed ID: 29327148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different role of zinc transporter 8 between type 1 diabetes mellitus and type 2 diabetes mellitus.
    Yi B; Huang G; Zhou Z
    J Diabetes Investig; 2016 Jul; 7(4):459-65. PubMed ID: 27181765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus.
    Dunseath G; Ananieva-Jordanova R; Coles R; Powell M; Amoroso M; Furmaniak J; Smith BR; Dayan C; Luzio S
    Clin Chim Acta; 2015 Jul; 447():90-5. PubMed ID: 26006309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against zinc transporter 8 further stratify the autoantibody-defined risk for type 1 diabetes in a general population of schoolchildren and have distinctive isoform binding patterns in different forms of autoimmune diabetes: results from the Karlsburg Type 1 Diabetes Risk Study.
    Baumann K; Kesselring K; Lampasona V; Walschus U; Kerner W; Wassmuth R; Schlosser M
    Diabet Med; 2021 Feb; 38(2):e14389. PubMed ID: 32799407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What has zinc transporter 8 autoimmunity taught us about type 1 diabetes?
    Williams CL; Long AE
    Diabetologia; 2019 Nov; 62(11):1969-1976. PubMed ID: 31444530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes.
    Énée É; Kratzer R; Arnoux JB; Barilleau E; Hamel Y; Marchi C; Beltrand J; Michaud B; Chatenoud L; Robert JJ; van Endert P
    Diabetes; 2012 Jul; 61(7):1779-84. PubMed ID: 22586580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against ZnT8 are rare in Central-European LADA patients and absent in MODY patients, including those positive for other autoantibodies.
    Heneberg P; Šimčíková D; Čecháková M; Rypáčková B; Kučera P; Anděl M
    J Diabetes Complications; 2019 Jan; 33(1):46-52. PubMed ID: 30377089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
    Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
    Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of conformational autoantibody epitopes in ZNT8.
    Wenzlau JM; Frisch LM; Hutton JC; Davidson HW
    Diabetes Metab Res Rev; 2011 Nov; 27(8):883-6. PubMed ID: 22069278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prokaryotic expression and characterization of the heterodimeric construction of ZnT8 and its application for autoantibodies detection in diabetes mellitus.
    Faccinetti NI; Guerra LL; Sabljic AV; Bombicino SS; Rovitto BD; Iacono RF; Poskus E; Trabucchi A; Valdez SN
    Microb Cell Fact; 2017 Nov; 16(1):196. PubMed ID: 29132366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple chimeric islet autoantigen IA2-ZnT8WR to facilitate islet autoantibody determination.
    Yu L; Liu Y; Miao D; Wenzlau J; Davidson H; Hutton J; Eisenbarth GS
    J Immunol Methods; 2010 Feb; 353(1-2):20-3. PubMed ID: 20035758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.